Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

ADC Therapeutics

Biotech & Life Sciences · Epalinges, Switzerland · Founded 2011 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$336M
Market cap · Apr/2026
Revenue
$73M
Latest reported FY

Investors

6 investors on ADC Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
MedImmune
Auven Therapeutics
Series B+ 4 investors entered at this stage
Wild Family Office
Redmile Group
AstraZeneca
TCGX

Global footprint

Where ADC Therapeutics has talent and traffic

AI talent share
0.4% of workforce is AI talent
(1 of 272 staff)
Core AI00%
Other AI10.37%
Non-AI workforce27199.63%
Web traffic by country
4.9K monthly visits
across markets
🇺🇸 United States81.6%
🇮🇳 India16.3%
🇹🇷 Turkey2%
Top 3 markets shown

Patent intelligence

$61M patent portfolio · 36 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$61M
18.0% of market cap · 5.4× smaller than top peer Genmab ($328M)
36 active patent families
Where ADC Therapeutics innovates Antiendomysial antibodiesMolecular biologyBiochemistryPharmaceutical drugPyrrole
Below peer median on Legal, Market, Economic, Technology

Quality vs same-sector peers

ADC Therapeutics on the five Patsnap quality dimensions

ADC Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where ADC Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across ADC Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See ADC Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo